You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 30, 2026
Sale
Calculated transaction value
$212.36K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 29, 2026
Public filing date
Sep 30, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$481.47
Sep 29, 2026
First close after public filing
$571.38
Oct 1, 2026
30-day return after filing
+4.78%
Through Oct 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 449 shares @ $472.97
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000152
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$5.65M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 29, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $188.82K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $574.89K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $240.61K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $57.87K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $664.16K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $97.35K |
| United Therapeutics Corp UTHR | Exercise | Sep 29, 2026 | $1.12M |
| United Therapeutics Corp UTHR Current | Sale | Sep 29, 2026 | $212.36K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $37.91K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $262.26K |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $1.02M |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $1.1M |
| United Therapeutics Corp UTHR | Sale | Sep 29, 2026 | $76.73K |